Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 3
1983 7
1984 4
1985 4
1986 3
1987 5
1988 4
1989 8
1990 8
1991 11
1992 10
1993 5
1994 4
1995 5
1996 6
1997 8
1998 7
1999 5
2000 5
2001 5
2002 5
2003 4
2004 5
2005 4
2006 6
2007 6
2008 4
2009 1
2010 3
2011 6
2012 6
2013 2
2014 7
2015 3
2016 3
2017 6
2018 5
2019 1
2020 3
2021 4
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2019 Feb;21(S1):S57-S78. doi: 10.1089/dia.2019.2505. Diabetes Technol Ther. 2019. PMID: 30785319 Review. No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2018 Feb;20(S1):S55-S70. doi: 10.1089/dia.2018.2505. Diabetes Technol Ther. 2018. PMID: 29437477 Review. No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2020 Feb;22(S1):S32-S46. doi: 10.1089/dia.2020.2503. Diabetes Technol Ther. 2020. PMID: 32069160 Review. No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2017 Feb;19(S1):S42-S58. doi: 10.1089/dia.2017.2505. Diabetes Technol Ther. 2017. PMID: 28192016 Review. No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2022 Mar;24(S1):S35-S57. doi: 10.1089/dia.2022.2503. Diabetes Technol Ther. 2022. PMID: 35475698 No abstract available.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2021 Jun;23(S2):S46-S68. doi: 10.1089/dia.2021.2504. Diabetes Technol Ther. 2021. PMID: 34061629 No abstract available.
New insulins and insulin therapy.
Danne T, Bolinder J. Danne T, et al. Among authors: bolinder j. Int J Clin Pract Suppl. 2011 Feb;(170):26-30. doi: 10.1111/j.1742-1241.2010.02576.x. Int J Clin Pract Suppl. 2011. PMID: 21323810 Review.
New Insulins, Biosimilars, and Insulin Therapy.
Danne T, Heinemann L, Bolinder J. Danne T, et al. Among authors: bolinder j. Diabetes Technol Ther. 2016 Feb;18 Suppl 1:S43-55. doi: 10.1089/dia.2016.2505. Diabetes Technol Ther. 2016. PMID: 26836429 Review. No abstract available.
195 results